Ixinity (trenonacog alfa) can effectively prevent and controlled bleeds in young children with severe or moderately severe ...

Altuvoct (efanesoctocog alfa) was approved in the U.K. as a treatment for patients with moderate or severe hemophilia A ages ...

Columnist Jennifer Lynne stresses the significance of hidden symptoms in the lives of those with bleeding disorders.

Columnist G Shellye Horowitz shares her approach to dating with chronic illness, particularly regarding when to discuss ...

Now that his adult sons manage their own hemophilia care, columnist Joe MacDonald wonders how he can best support them.

Four years after receiving Hemgenix in a Phase 3 trial, bleeding rates and the use of replacement therapy are low for men ...

After years of medical issues, columnist G Shellye Horowitz has acquired numerous assistive devices, which come in handy ...

Antibody therapy Mim8 was found to be safe and effective for controlling bleeds in children with hemophilia A in a Phase 3 ...

Valentine’s Day is a holiday that celebrates love. However, the day’s origin doesn’t involve a hard-to-get dinner reservation, the perfect Valentine’s card, and the best box of chocolates, but rather ...

When people talk about hemophilia, some deliberately avoid calling it a disability. Instead, they’ll say “a medical condition” or “a health challenge,” as if disability were a negative label. Some who ...

Lyrics from the stage musical "Wicked" remind columnist Joe MacDonald of the journey his family has taken with his oldest son's hemophilia.

Metagenomi is now working on preclinical studies to advance MGX-001, its experimental gene-editing therapy for hemophilia A, with the goal of bringing the treatment candidate into clinical trials in ...